Search alternatives:
changes decrease » change increases (Expand Search), larger decrease (Expand Search), largest decrease (Expand Search)
force decrease » forces increased (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
changes decrease » change increases (Expand Search), larger decrease (Expand Search), largest decrease (Expand Search)
force decrease » forces increased (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
-
541
-
542
Decreased CD28 signaling and activated CTLA-4 pathways during acute thymic atrophy.
Published 2011“…CTLA-4, CD86 and CD80 mRNA levels were significantly increased while CD28 and TCR signaling-related mRNA levels were decreased. …”
-
543
Force-pCa curves for the model and effects of changes in crossbridge affinity.
Published 2015“…<p>The effects of crossbridge inhibition by substances such as blebbistatin and sodium vanadate were simulated by changing the dissociation constant of myosin (<i>K</i><sub>DM</sub>), resulting in significant changes in calcium sensitivity. …”
-
544
-
545
-
546
-
547
-
548
-
549
-
550
-
551
-
552
Fold change of differentially expressed genes relative to promoter methylation profile.
Published 2013“…<p>Each point represents one gene with significant change in expression (p < 0.05) in addition to having at least two measured methylation sites within its promoter region. …”
-
553
VRK1 overexpression is seen in human breast cancer and is associated with decreased relapse-free survival.
Published 2018“…Data for cancer subtypes are shown in boxes numbered 1–11: 1: benign breast neoplasm (rank 6459, 1.4 fold-change, NS), 2: breast carcinoma (rank 833, 1.5 fold-change, p = 3.83x10<sup>-5</sup>), 3: breast phyllodes tumor (rank 512, 1.2 fold-change, p = 0.002), 4: ductal breast carcinoma in situ (rank 1969, 1.5 fold-change, p = 0.002), 5: invasive breast carcinoma (rank 1060, 1.6 fold-change, p = 1.28x10<sup>-5</sup>), 6: invasive ductal and invasive lobular breast carcinoma (rank 941, 1.5 fold-change, p = 6.76x10<sup>-22</sup>), 7: invasive ductal breast carcinoma (rank 613, 1.5-fold change, p = 2.71x10<sup>-71</sup>), 8: invasive lobular breast carcinoma (rank 947, 1.3 fold-change, p = 3.64x10<sup>-28</sup>), 9: medullary breast carcinoma (rank 400, 1.8 fold-change, p = 3.25x10<sup>-12</sup>), 10: mucinous breast carcinoma (rank 1932, 1.4 fold-change, p = 7.41x10<sup>-10</sup>) and 11: tubular breast carcinoma (rank 1253, 1.4 fold-change, p = 1.24x10<sup>-17</sup>). …”
-
554
Cycloheximide (CHX) treatment decreases production of rRNA transcripts by POLR1 and POLR3.
Published 2019“…(D) Schematic summary of CHX versus TBEV effect on the expression of POLR1 and POLR3 transcripts. (↓) indicates observed decrease of the RNA levels and (─) indicates no change in RNA levels.…”
-
555
The <i>rcan-1</i> rearrangement allele decreases expression of <i>rcan-1</i>.
Published 2020“…The gene with the largest and most significant expression decrease was <i>rcan-1</i>. Red: p<0.01, log<sub>2</sub>(Fold Change) > 1. …”
-
556
-
557
-
558
-
559
-
560